Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Hastings

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Toxicology|February 13, 2001
Pre-clinical methods for detecting the hypersensitivity potential of pharmaceuticals: regulatory considerationsK L Hastings
Toxicologic Pathology|May 1, 1996
Regulatory issues of importance to developing anti-HIV therapeuticsK L Hastings
Toxicology Letters|February 18, 1999
What are the prospects for regulation in immunotoxicology?K L Hastings
Human & Experimental Toxicology|August 3, 2000
Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal modelsK L Hastings
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|November 1, 1987
Induction of ethylenediamine hypersensitivity in the guinea pig and the development of ELISA and lymphocyte blastogenesis techniques for its characterizationC Babiuk, K L Hastings, J H Dean
International Journal of Immunopharmacology|January 1, 1991
Generation and detection of neoantigens in guinea pig liver slices incubated with halothaneA P Brown, K L Hastings, A J Gandolfi
Immunopharmacology and Immunotoxicology|February 1, 1995
Trifluoroacetylation potentiates the humoral immune response to halothane in the guinea pigK L Hastings, C Thomas, A P Brown, et al.
British Journal of Anaesthesia|December 1, 1991
Screening for antibodies associated with halothane hepatitisK L Hastings, C Thomas, A K Hubbard, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Covalent binding of a halothane metabolite and neoantigen production in guinea pig liver slicesA P Brown, K L Hastings, A J Gandolfi, et al.
Drug and Chemical Toxicology|January 1, 1994
Use of staphylococcal enterotoxin A-induced lymphoproliferation and interleukin 2 production as indicators of immunotoxicityL L Reid, K L Hastings, A J Gandolfi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Toxicology|February 13, 2001
Pre-clinical methods for detecting the hypersensitivity potential of pharmaceuticals: regulatory considerationsK L Hastings
Toxicologic Pathology|May 1, 1996
Regulatory issues of importance to developing anti-HIV therapeuticsK L Hastings
Toxicology Letters|February 18, 1999
What are the prospects for regulation in immunotoxicology?K L Hastings
Human & Experimental Toxicology|August 3, 2000
Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal modelsK L Hastings
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|November 1, 1987
Induction of ethylenediamine hypersensitivity in the guinea pig and the development of ELISA and lymphocyte blastogenesis techniques for its characterizationC Babiuk, K L Hastings, J H Dean
International Journal of Immunopharmacology|January 1, 1991
Generation and detection of neoantigens in guinea pig liver slices incubated with halothaneA P Brown, K L Hastings, A J Gandolfi
Immunopharmacology and Immunotoxicology|February 1, 1995
Trifluoroacetylation potentiates the humoral immune response to halothane in the guinea pigK L Hastings, C Thomas, A P Brown, et al.
British Journal of Anaesthesia|December 1, 1991
Screening for antibodies associated with halothane hepatitisK L Hastings, C Thomas, A K Hubbard, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Covalent binding of a halothane metabolite and neoantigen production in guinea pig liver slicesA P Brown, K L Hastings, A J Gandolfi, et al.
Drug and Chemical Toxicology|January 1, 1994
Use of staphylococcal enterotoxin A-induced lymphoproliferation and interleukin 2 production as indicators of immunotoxicityL L Reid, K L Hastings, A J Gandolfi, et al.
Pageof 2